The duration of subject participation is approximately 2 to 3 months. The study will be conducted during the influenza "off-season" in the US. After completion of the study all subjects will be offered and strongly encouraged to receive an inactivated influenza vaccine approved for use in the US for the 2017-2018 influenza season.